Related Experiment Video
Updated: May 3, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
Biologically active ligands for yersinia outer protein H (YopH): feature based pharmacophore screening, docking and
Thangaraju Tamilvanan, Waheeta Hopper1
1Department of Bioinformatics, School of Bioengineering, Faculty of Engineering & Technology, SRM University, Kattankulathur-603203, Tamil Nadu, India. hod.bioinfo@ktr.srmuniv.ac.in.
Abstract:
Yersinia pestis, a Gram negative bacillus, spreads via lymphatic to lymph nodes and to all organs through the bloodstream, causing plague. Yersinia outer protein H (YopH) is one of the important effector proteins, which paralyzes lymphocytes and macrophages by dephosphorylating critical tyrosine kinases and signal transduction molecules. The purpose of the study is to generate a three-dimensional (3D) pharmacophore model by using diverse sets of YopH inhibitors, which would be useful for designing of potential antitoxin. In this study, we have selected 60 biologically active inhibitors of YopH to perform Ligand based pharmacophore study to elucidate the important structural features responsible for biological activity. Pharmacophore model demonstrated the importance of two acceptors, one hydrophobic and two aromatic features toward the biological activity. Based on these features, different databases were screened to identify novel compounds and these ligands were subjected for docking, ADME properties and Binding energy prediction. Post docking validation was performed using molecular dynamics simulation for selected ligands to calculate the Root Mean Square Deviation (RMSD) and Root Mean Square Fluctuation (RMSF). The ligands, ASN03270114, Mol_252138, Mol_31073 and ZINC04237078 may act as inhibitors against YopH of Y. pestis.
Insights
Researchers developed a 3D pharmacophore model to identify new Yersinia pestis YopH inhibitors. This model aids in designing potential antitoxins by highlighting key structural features for YopH inhibition.
Area of Science:
- Microbiology
- Structural Biology
- Drug Discovery
Background:
- Yersinia pestis causes plague by spreading through the lymphatic system and bloodstream.
- Yersinia outer protein H (YopH) is a key effector protein that impairs immune cells like lymphocytes and macrophages.
- YopH functions by dephosphorylating crucial tyrosine kinases and signal transduction molecules, leading to immune paralysis.
Purpose of the Study:
- To create a three-dimensional (3D) pharmacophore model for Yersinia outer protein H (YopH) inhibitors.
- To identify essential structural features contributing to YopH inhibitory activity.
- To facilitate the design of novel antitoxin compounds against Yersinia pestis.
Main Methods:
- A ligand-based pharmacophore study was conducted using 60 biologically active YopH inhibitors.
- Database screening identified novel compounds based on the pharmacophore model.
- In silico methods including docking, ADME property prediction, binding energy calculation, and molecular dynamics simulations (RMSD, RMSF) were employed for validation.
Main Results:
- The pharmacophore model revealed that two acceptor, one hydrophobic, and two aromatic features are critical for YopH inhibition.
- Screening and subsequent analyses identified four potential YopH inhibitors: ASN03270114, Mol_252138, Mol_31073, and ZINC04237078.
- Molecular dynamics simulations confirmed the stability and binding characteristics of the identified compounds.
Conclusions:
- The developed 3D pharmacophore model effectively captures essential features for YopH inhibition.
- The identified compounds show promise as potential inhibitors of Yersinia pestis YopH.
- This study provides a foundation for designing new antitoxin therapies against plague.
More Related Videos
Related Concept Videos
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites
Ligand Binding and Linkage

